rss
J Neurol Neurosurg Psychiatry 2004;75:209-212 doi:10.1136/jnnp.2003.017822
  • Paper

Rate and correlates of weight change in Huntington’s disease*

  1. J M Hamilton1,
  2. T Wolfson2,
  3. G M Peavy1,
  4. M W Jacobson3,
  5. J Corey-Bloom1
  1. 1Department of Neurosciences, University of California at San Diego, San Diego, California, USA
  2. 2Department of Family and Preventive Medicine, University of California at San Diego
  3. 3Department of Psychiatry, University of California at San Diego
  1. Correspondence to:
 Dr Joanne M Hamilton
 Department of Neurosciences, 9500 Gilman Drive (0948), La Jolla, CA 92093-0948, USA (for the investigators of the Huntington Study Group); jmhamiltonucsd.edu
  • Received 29 April 2003
  • Accepted 21 June 2003
  • Revised 18 June 2003

Abstract

Objective: To determine the rate and correlates of weight change in a large, well characterised sample of patients with Huntington’s disease followed at 44 sites by the Huntington Study Group.

Participants and methods: Weight change was assessed in 927 adults with a definite diagnosis of Huntington’s disease who were followed prospectively for (mean (SD)) 3.4 (1.4) years. The unified Huntington’s disease rating scale was used to assess weight, motor dysfunction (including chorea and dystonia), depressive symptoms, and functional decline.

Results: Random effects modelling determined that patients gained an average of 0.11 (1.7) kg/year and their chorea scores increased by 0.36 (0.78) points/year. There were significant but weak relations between weight loss and increasingly severe chorea (r  =  −0.13), worse baseline motor performance (r  =  −0.12), less severe baseline depressed mood (r  =  0.14), and poorer baseline independence ratings (r  =  0.07). Patients who were within 0 to 2 years of symptom onset at the time of the baseline visit gained more weight than those with longer disease duration.

Conclusions: Weight loss following symptom onset is not a consistent feature of Huntington’s disease. The mechanisms contributing to weight change in this condition are unclear and probably multifactorial. Future studies examining asymptomatic carriers of the mutation could be helpful in identifying incipience of low body weight and may be better suited for identifying clinical correlates of weight loss than studies in symptomatic patients.

Footnotes

  • * See appendix (web only) for a complete list of the members of the Huntington Study Group.

  • Competing interests: none declared

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs